Results of superior vena cava resection for lung cancer - Analysis of prognostic factors

被引:60
作者
Spaggiari, L
Magdeleinat, P
Kondo, H
Thomas, P
Leon, ME
Rollet, G
Regnard, JF
Tsuchiya, R
Pastorino, U
机构
[1] European Inst Oncol, Dept Thorac Surg, I-20141 Milan, Italy
[2] Hop Hotel Dieu, Dept Thorac Surg, F-75181 Paris, France
[3] Natl Canc Ctr, Dept Thorac Surg, Tokyo 104, Japan
[4] St Marguerite Univ Hosp, Dept Thorac Surg, Marseille, France
[5] European Inst Oncol, Dept Biostat, Milan, Italy
关键词
lung cancer; superior vena cava; surgery; extended resection; T4; mediastinal surgery; vascular surgery;
D O I
10.1016/j.lungcan.2003.11.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The benefits of superior vena cava (SVC) resection for lung cancer remain controversial. Data obtained in four international centers were analyzed in order to identify prognostic factors and thus guide in future patient selection. Materials and methods: Retrospective study. Prognostic factors were examined by logistic regression for postoperative morbidity/mortality using the Kaplan-Meier method (log rank test) and the Cox proportional-hazard model for survival. Results: From 1963 to 2000, 109 patients underwent SVC resection. Induction treatment was given to 23 (21%) patients. The SVC was resected for T involvement in 78 (72%) cases and for N involvement in 31 (28%) cases. Fifty-five (50.5%) patients underwent pneumonectomy (20 with carinal resection), while the remaining underwent lobar resections. Prosthetic SVC replacement was performed in 28 (26%) patients; partial resection with running suture (53%), vascular stapler (13%), or patch (7%) was performed in 80 patients; 1 patient did not undergo reconstruction. Pathological examination identified direct involvement (T4) in 66 (60%) patients and N2 disease in 55 (50%) patients. Major postoperative morbidity and mortality were 30 and 12%, respectively. Median intensive care unit stay was 3 days, while median hospital stay was 16 days. Five-year survival was at 21%, with median survival at 11 months. In multiple regression analysis, induction treatment was associated with an increased risk of major complications (P = 0.016). None of the factors assessed demonstrated an association with postoperative death. In multivariate survival analysis, both pneumonectomy and complete resection of the SVC with prosthetic replacement were associated with a significant increased risk of death (P = 0.0013 and 0.014, respectively). Conclusions: The radical resection of lung cancer involving the SVC may result in a permanent cure in carefully selected patients. The type of pulmonary resection (i.e., pneumonectomy) and the type of SVC resection (i.e., complete resection with prosthetic replacement) are the prognostic factors with the greatest adverse effect on survival. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
[41]   Resection of the sidewall of superior vena cava using video-assisted thoracic surgery mechanical suture technique [J].
Xu, Xin ;
Qiu, Yuan ;
Pan, Hui ;
Mo, Lili ;
Chen, Hanzhang ;
He, Jianxing .
JOURNAL OF THORACIC DISEASE, 2016, 8 (03) :612-616
[42]   Management of superior vena cava syndrome in critically ill cancer patients [J].
Morin, Sarah ;
Grateau, Adeline ;
Reuter, Danielle ;
de Kerviler, Eric ;
de Margerie-Mellon, Constance ;
de Bazelaire, Cedric ;
Zafrani, Lara ;
Schlemmer, Benoit ;
Azoulay, Elie ;
Canet, Emmanuel .
SUPPORTIVE CARE IN CANCER, 2018, 26 (02) :521-528
[43]   Treatment of malignant superior vena cava syndrome by endovascular stent insertion experience on 52 patients with lung cancer [J].
Urruticoechea, A ;
Mesía, R ;
Domínguez, J ;
Falo, C ;
Escalante, E ;
Montes, A ;
Sancho, C ;
Cardenal, F ;
Majem, M ;
Germà, JR .
LUNG CANCER, 2004, 43 (02) :209-214
[44]   Longevity after radiotherapy of stage III lung cancer: superior vena cava obstruction is associated with early mortality [J].
Ampil, Federico L. ;
Caldito, Gloria ;
Devarakonda, Srinivas ;
Vora, Moiz ;
Mills, Glenn ;
Milligan, Shawn .
ANNALS OF PALLIATIVE MEDICINE, 2018, 7 (02) :242-248
[45]   Multivisceral Resection for Colon Cancer: Analysis of Prognostic Factors [J].
Lopez-Cano, Manuel ;
Manas, Maria Jose ;
Hermosilla, Eduardo ;
Espin, Eloy .
DIGESTIVE SURGERY, 2010, 27 (03) :238-245
[46]   Superior vena cava as initiator of atrial fibrillation: Factors related to its arrhythmogenicity [J].
Higuchi, Koji ;
Yamauchi, Yasuteru ;
Hirao, Kenzo ;
Sasaki, Takeshi ;
Hachiya, Hitoshi ;
Sekiguchi, Yukio ;
Nitta, Junichi ;
Isobe, Mitsuaki .
HEART RHYTHM, 2010, 7 (09) :1186-1191
[47]   Identifying partial anomalous pulmonary venous connection in the superior vena cava before pulmonary resection [J].
Matsuoka, Hiroyasu ;
Matsubara, Hirochika ;
Onuki, Yuichiro ;
Uchida, Tsuyoshi ;
Nakajima, Hiroyuki .
GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (09) :1313-1319
[48]   Identifying partial anomalous pulmonary venous connection in the superior vena cava before pulmonary resection [J].
Hiroyasu Matsuoka ;
Hirochika Matsubara ;
Yuichiro Onuki ;
Tsuyoshi Uchida ;
Hiroyuki Nakajima .
General Thoracic and Cardiovascular Surgery, 2021, 69 :1313-1319
[49]   Successful resection of malignant hemangiopericytoma originating from left neck and involving superior vena cava [J].
T Minchev ;
E Manolov ;
V Marinchev ;
I Todorov ;
V Georgiev ;
I Stoimenov ;
G Kirova ;
H Mavrov .
Journal of Cardiothoracic Surgery, 8 (Suppl 1)
[50]   Initial experience of thoracoscopic lobectomy with partial removal of the superior vena cava for lung cancers [J].
Xu, Xin ;
Chen, Hanzhang ;
Yin, Weiqiang ;
Shao, Wenlong ;
Wang, Wei ;
Peng, Guilin ;
Huang, Jun ;
He, Jianxing .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 47 (01) :E8-E12